1.
Dementia prevention, intervention, and care
by Livingston, Gill
The Lancet (British edition), 2017-12-16, Vol.390 (10113), p.2673-2734
2.
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
by Sperling, Reisa
Neuron (Cambridge, Mass.), 2014-11-05, Vol.84 (3), p.608-622
3.
Combination HIV prevention for female sex workers: what is the evidence?
by Bekker, Linda-Gail, Prof
The Lancet (British edition), 2015, Vol.385 (9962), p.72-87
4.
Rheumatic heart disease
by Marijon, Eloi, Dr
The Lancet (British edition), 2012, Vol.379 (9819), p.953-964
5.
Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA
by Bauer, Ursula E, PhD
The Lancet (British edition), 2014, Vol.384 (9937), p.45-52
6.
Fifty Communities Putting Prevention to Work: Accelerating Chronic Disease Prevention Through Policy, Systems and Environmental Change
by Bunnell, Rebecca
Journal of community health, 2012-02-10, Vol.37 (5), p.1081-1090
7.
Non-communicable diseases in the Arab world
by Rahim, Hanan F Abdul, Dr
The Lancet (British edition), 2014, Vol.383 (9914), p.356-367
8.
Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries
by Moodie, Rob, Prof
The Lancet (British edition), 2013, Vol.381 (9867), p.670-679
9.
A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER)...
by Ngandu, Tiia, PhD
The Lancet (British edition), 2015, Vol.385 (9984), p.2255-2263
10.
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
by Prepared, b
Heart (British Cardiac Society), 2005-12, Vol.91 (suppl 5), p.v1-v52
11.
Omega-3 fatty acids: a comprehensive review of their role in health and disease
by Yashodhara, B M
Postgraduate medical journal, 2009-02, Vol.85 (1000), p.84-90
12.
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Ang...
by Dahlöf, Björn
The Lancet (British edition), 2005-09-10, Vol.366 (9489), p.895-906
13.
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiologica...
by Yusuf, Salim, Prof
The Lancet (British edition), 2011, Vol.378 (9798), p.1231-1243
14.
Global perspectives for prevention of infectious diseases associated with mass gatherings
by Abubakar, Ibrahim, Prof
The Lancet infectious diseases, 2012, Vol.12 (1), p.66-74
15.
Effective tobacco control is key to rapid progress in reduction of non-communicable diseases
by Glantz, Stanton, Prof
The Lancet (British edition), 2012, Vol.379 (9822), p.1269-1271
16.
Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study
by Yang, Shigui, PhD
The Lancet infectious diseases, 2017, Vol.17 (7), p.716-725
17.
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
by Blaha, Michael J, Dr
The Lancet (British edition), 2011, Vol.378 (9792), p.684-692
18.
Concern over Zika virus grips the world
by Samarasekera, Udani
The Lancet (British edition), 2016, Vol.387 (10018), p.521-524
19.
From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century
by Blacher, Jacques, Prof
The Lancet (British edition), 2016, Vol.388 (10043), p.530-532
20.
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study
by Windecker, Stephan
The American heart journal, 2017-02, Vol.184, p.81-87
